Krasel Cornelius, Zabel Ulrike, Lorenz Kristina, Reiner Susanne, Al-Sabah Suleiman, Lohse Martin J
Institute of Pharmacology and Toxicology, Versbacher Strasse 9, D-97078 Wuerzburg, Germany.
J Biol Chem. 2008 Nov 14;283(46):31840-8. doi: 10.1074/jbc.M806086200. Epub 2008 Sep 18.
Homologous desensitization of beta2-adrenergic and other G-protein-coupled receptors is a two-step process. After phosphorylation of agonist-occupied receptors by G-protein-coupled receptor kinases, they bind beta-arrestins, which triggers desensitization and internalization of the receptors. Because it is not known which regions of the receptor are recognized by beta-arrestins, we have investigated beta-arrestin interaction and internalization of a set of mutants of the human beta2-adrenergic receptor. Mutation of the four serine/threonine residues between residues 355 and 364 led to the loss of agonist-induced receptor-beta-arrestin2 interaction as revealed by fluorescence resonance energy transfer (FRET), translocation of beta-arrestin2 to the plasma membrane, and receptor internalization. Mutation of all seven serine/threonine residues distal to residue 381 did not affect agonist-induced receptor internalization and beta-arrestin2 translocation. A beta2-adrenergic receptor truncated distal to residue 381 interacted normally with beta-arrestin2, whereas its ability to internalize in an agonist-dependent manner was compromised. A similar impairment of internalization was observed when only the last eight residues of the C terminus were deleted. Our experiments show that the C terminus distal to residue 381 does not affect the initial interaction between receptor and beta-arrestin, but its last eight amino acids facilitate receptor internalization in concert with beta-arrestin2.
β2 - 肾上腺素能受体及其他G蛋白偶联受体的同源脱敏是一个两步过程。在G蛋白偶联受体激酶将激动剂占据的受体磷酸化后,它们结合β - 抑制蛋白,从而触发受体的脱敏和内化。由于尚不清楚β - 抑制蛋白识别受体的哪些区域,我们研究了一组人β2 - 肾上腺素能受体突变体与β - 抑制蛋白的相互作用及内化情况。355位至364位之间四个丝氨酸/苏氨酸残基的突变导致激动剂诱导的受体 - β - 抑制蛋白2相互作用丧失,这通过荧光共振能量转移(FRET)、β - 抑制蛋白2向质膜的转位以及受体内化得以揭示。381位远端所有七个丝氨酸/苏氨酸残基的突变并不影响激动剂诱导的受体内化和β - 抑制蛋白2转位。一个在381位远端截断的β2 - 肾上腺素能受体与β - 抑制蛋白2正常相互作用,但其以激动剂依赖方式内化的能力受损。当仅缺失C末端的最后八个残基时,观察到类似的内化受损情况。我们的实验表明,381位远端的C末端不影响受体与β - 抑制蛋白的初始相互作用,但其最后八个氨基酸与β - 抑制蛋白2协同促进受体内化。